Zhengle Zhang
238 Jiefang Road
Wuhan, 430060, China
Wuhan, 430060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Identification of a Novel PDRG1-EZH2-p21 Pathway Controlling Senescence and Tumor Progression in Hepatocellular Carcinoma.
Journal: International journal of biological sciences
Published: November 27, 2025
ASO Author Reflections: How to Visualize Pancreatic Duct Injury During Pancreatic Enucleation.
Journal: Annals of surgical oncology
Published: July 17, 2025
Enucleation of Pancreatic Lesions: The Outcomes and Experiences from Two Centers.
Journal: Annals of surgical oncology
Published: February 03, 2025
Correction: Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells.
Journal: Cell & bioscience
Published: October 26, 2023
Alterations of oral microbiota are associated with the development and severity of acute pancreatitis.
Journal: Journal of oral microbiology
Published: October 09, 2023
Discontinuous Adaptive Impulsive Control of Uncertain System With Extension in Stochastic Perturbation and Actuator Saturation.
Journal: IEEE transactions on cybernetics
Published: May 01, 2023
A Novel Ferroptosis-Related Signature for Prediction of Prognosis, Immune Profiles and Drug Sensitivity in Hepatocellular Carcinoma Patients.
Journal: Current oncology (Toronto, Ont.)
Published: August 01, 2022
A novel signature of combing cuproptosis- with ferroptosis-related genes for prediction of prognosis, immunologic therapy responses and drug sensitivity in hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: July 22, 2022
CASC9 potentiates gemcitabine resistance in pancreatic cancer by reciprocally activating NRF2 and the NF-κB signaling pathway.
Journal: Cell biology and toxicology
Published: June 04, 2022
TRIM47 accelerates aerobic glycolysis and tumor progression through regulating ubiquitination of FBP1 in pancreatic cancer.
Journal: Pharmacological research
Published: October 10, 2020
Hypoxia-induced lncRNA CASC9 enhances glycolysis and the epithelial-mesenchymal transition of pancreatic cancer by a positive feedback loop with AKT/HIF-1α signaling.
Journal: American journal of cancer research
Published: September 12, 2020
ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer.
Journal: Molecular therapy oncolytics
Published: June 22, 2019
Last Updated: 09/26/2026